^
BIOMARKER:

ER negative

i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta
Entrez ID:
ER negative
Breast Cancer
toremifene
Resistant: A1 - Approval
ER negative
Breast Cancer
anastrozole
Sensitive: A1 - Approval
ER negative
HER2 Negative Breast Cancer
docetaxel
Resistant: C2 – Inclusion Criteria
ER negative
HER2 Positive Breast Cancer
docetaxel
Resistant: C2 – Inclusion Criteria
ER negative
HER2 Positive Breast Cancer
trastuzumab + pertuzumab
Sensitive: C2 – Inclusion Criteria
ER negative
Breast Cancer
trastuzumab + pertuzumab
Sensitive: C2 – Inclusion Criteria
ER negative
HER2 Positive Breast Cancer
pertuzumab + Herzuma (trastuzumab biosimilar)
Sensitive: C3 – Early Trials
ER negative
HER2 Positive Breast Cancer
TCHP
Sensitive: C3 – Early Trials
ER negative
HER2 Negative Breast Cancer
doxorubicin hydrochloride
Resistant: D – Preclinical
ER negative
HER2 Positive Breast Cancer
doxorubicin hydrochloride
Resistant: D – Preclinical